Effects of Extracorporeal Treatment in Patients With Acute Poisoning

NCT06798129 · tracked via the Priya Life Science China tracker

Sponsor

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Phase

Observational

Started

2015-01-01

Last updated

2025-12-05

Condition(s) studied

PoisoningExtracorporeal Treatment

Investigational drug(s) / intervention(s)

Extracorporeal Treatment

Extracorporeal Treatment: Extracorporeal treatments include hemoperfusion, hemodialysis, continuous kidney replacement therapy, and plasma exchange.

Study summary

This study aims to estimate the effect of extracorporeal treatments (ECTRs) on 28-day survival in patients with acute poisoning. The treatment strategy was receipt of ECTR (hemoperfusion, hemodialysis, continuous kidney replacement therapy, and/or or plasma exchange) versus a non-ECTR strategy.

Eligibility

Sex

ALL

Min age

12 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * 12 years of age and older * History of acute poisoning Exclusion Criteria: * missing records in survival outcome

Primary outcome measure(s)

Survival outcome — 28 days within the index date of presentation at emergency department

Trial sites (1)

Facility	City	Region	Status
Nanjing Drum Tower Hospital	Nanjing	Jiangsu

More The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School trials in China

Ipsilateral Versus Bilateral Systematic Biopsy Combined With MRI/Ultrasound Cognitive Fusion Targeted Biopsy for Prostate Cancer Diagnosis Recruiting

Effects of Different Secukinumab Maintenance Regimens on Long-Term Outcomes in Patients With Psoriasis Starting soon

Prediction of Detoxification Effect of Fat Emulsion Based on Drug Diffusion Law Active, not recruiting

Diagnostic Value of the Liver Inflammation Index for MASH in Patients With T2DM and MAFLD Recruiting

Intraoperative Ultrasound Assessment of Coronary Artery and Bypass Graft Blood Flow During CABG Starting soon

Other trials for the same condition

Prediction of Detoxification Effect of Fat Emulsion Based on Drug Diffusion Law Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06798129 on ClinicalTrials.gov ↗ ← All trials in China